Chongqing Lummy Pharmaceutical (300006) — Strategic Asset Allocation Index
Chongqing Lummy Pharmaceutical (300006) has a Strategic Asset Allocation Index of 14.5% as of September 2023. Strategic assets (PP&E of CN¥304.16 Million plus long-term investments of CN¥-) total CN¥304.16 Million, measured against net assets of CN¥2.10 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300006 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Chongqing Lummy Pharmaceutical Strategic Asset Allocation Index (2006–2022)
This chart shows how Chongqing Lummy Pharmaceutical's Strategic Asset Allocation Index has evolved across 17 annual periods from 2006 to 2022. As of September 2023, the index stands at 14.5%, representing strategic assets of CN¥304.16 Million against net assets of CN¥2.10 Billion CNY. For live market cap and overall valuation, see how much is Chongqing Lummy Pharmaceutical worth.
Annual Strategic Asset Allocation Index for Chongqing Lummy Pharmaceutical (2006–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Chongqing Lummy Pharmaceutical from 2006 to 2022, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Chongqing Lummy Pharmaceutical's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 15.6% | CN¥339.92 Million | CN¥339.92 Million | CN¥- | CN¥2.18 Billion | ▼ -2.2 pp |
| 2021 | 17.7% | CN¥392.49 Million | CN¥392.49 Million | CN¥- | CN¥2.21 Billion | ▼ -19.6 pp |
| 2020 | 37.3% | CN¥459.97 Million | CN¥459.97 Million | CN¥- | CN¥1.23 Billion | ▲ +1.1 pp |
| 2019 | 36.3% | CN¥600.25 Million | CN¥600.25 Million | CN¥- | CN¥1.65 Billion | ▼ -32.6 pp |
| 2018 | 68.9% | CN¥1.19 Billion | CN¥685.83 Million | CN¥502.58 Million | CN¥1.72 Billion | ▲ +5.6 pp |
| 2017 | 63.3% | CN¥1.09 Billion | CN¥781.00 Million | CN¥309.38 Million | CN¥1.72 Billion | ▲ +4.1 pp |
| 2016 | 59.1% | CN¥990.32 Million | CN¥871.33 Million | CN¥118.99 Million | CN¥1.67 Billion | ▼ -0.1 pp |
| 2015 | 59.3% | CN¥1.00 Billion | CN¥943.09 Million | CN¥58.60 Million | CN¥1.69 Billion | ▼ -37.3 pp |
| 2014 | 96.6% | CN¥981.87 Million | CN¥981.87 Million | CN¥- | CN¥1.02 Billion | ▲ +12.1 pp |
| 2013 | 84.4% | CN¥950.29 Million | CN¥950.29 Million | CN¥- | CN¥1.13 Billion | ▲ +5.1 pp |
| 2012 | 79.3% | CN¥563.64 Million | CN¥563.64 Million | CN¥- | CN¥710.51 Million | ▲ +17.2 pp |
| 2011 | 62.1% | CN¥410.17 Million | CN¥410.17 Million | CN¥- | CN¥660.17 Million | ▲ +19.6 pp |
| 2010 | 42.5% | CN¥238.88 Million | CN¥238.88 Million | CN¥- | CN¥561.59 Million | ▲ +28.8 pp |
| 2009 | 13.7% | CN¥72.03 Million | CN¥72.03 Million | CN¥- | CN¥525.08 Million | ▼ -29.7 pp |
| 2008 | 43.4% | CN¥59.76 Million | CN¥59.76 Million | CN¥- | CN¥137.79 Million | ▼ -7.7 pp |
| 2007 | 51.1% | CN¥55.14 Million | CN¥55.14 Million | CN¥- | CN¥107.91 Million | ▲ +3.6 pp |
| 2006 | 47.5% | CN¥30.56 Million | CN¥30.56 Million | CN¥- | CN¥64.39 Million | — |